Multi-antibiotic Resistance Clinical Trial
Official title:
Evaluation of the Prevalence and Antibiotic Susceptibility Pattern of Multidrug Resistance Bacteria and Its Association With Patients' Predictive Factors
1. To determine the prevalence of multidrug resistance bacteria in patient with different infections 2. To evaluate patients' predictive risk factors of antimicrobial resistance 3. To assess the association between patients' factors and prevalence of MDR bacteria
Antimicrobial resistance is one of the most critical public health issue in this century . WHO declared antimicrobial resistance as one of the top ten global health threats that impend the effective management and prevention of evolving infections . Antimicrobial resistance nowadays poses a big challenge because of the emerging of resistance to the antibiotics that previously effective and development of multidrug resistance infections with subsequent increase in morbidity, mortality and financial loss . In spite of WHO health strategies that taken to face multidrug resistance problem, the burden of antimicrobial resistance in Europe is compared with combined burden of influenza and HIVS .while in USA the estimated antibiotics resistance infections is 2.8 millions and the related deaths exceeded 35,000 every year and expected to reach to ten million deaths with collective cost of 100 trillion USD annually in 2050 . Numerous studies reported that self-medications, improper prescription, overuse of antibiotics, deficiency of antibiotics susceptibility test and limited knowledge and attitude of population towards antibiotics are the main factors that lead to antibiotics efficacy being reduced with long hospital stay. Other studies stated that the predictive indicators of MDR tragedy are age, gender, comorbidities, previous hospital stay or antibiotic use . In low and middle income countries like IRAQ there is a difficulty in estimation the scope of antibiotics resistance problem and its evolving over time due to the lack of surveillance, besides alarmingly excessive antibiotics consumption added other challenges and urged us to aim this study . ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03309358 -
A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis
|
Phase 1 | |
Completed |
NCT02909946 -
Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents
|
N/A | |
Recruiting |
NCT04335383 -
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies
|
||
Recruiting |
NCT04181112 -
Fecal Transplant for MDRO Decolonization
|
N/A | |
Completed |
NCT05048693 -
Use of New Antibiotics in Sweden
|
||
Completed |
NCT05897801 -
Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO
|
||
Completed |
NCT04212130 -
Can Environmental Cleanliness be Assessed by BCA (Bicinchoninic Acid) Method
|
N/A | |
Completed |
NCT05549427 -
Ventilator Associated Pneumonia by Multi-Drug Resistant Organism
|
||
Not yet recruiting |
NCT06370299 -
Screening of Multidrug Resistant Bacteria, and the Clinical Implication for the Patient
|
||
Recruiting |
NCT06148480 -
Perinatal Transmission of MDR Bacteria
|
||
Recruiting |
NCT04995133 -
Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.
|
Phase 4 | |
Recruiting |
NCT03921645 -
Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia
|
N/A | |
Completed |
NCT06199141 -
Multi-drug Resistant Gram-negative Bacteria and Veno-venous Extracorporeal Membrane Oxygenation (ECMO)
|
||
Recruiting |
NCT04759001 -
FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05791396 -
FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae
|
Phase 1/Phase 2 | |
Terminated |
NCT02906774 -
Fecal Transplant for MDR Pathogen Decolonization
|
||
Recruiting |
NCT06036628 -
Resistant Bacteria in Children in France
|